Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone ; volume:4 ; number:1 ; day:13 ; month:8 ; year:2008 ; pages:1-8 ; date:12.2008
BMC veterinary research ; 4, Heft 1 (13.8.2008), 1-8, 12.2008
- Urheber
-
Webster, Joshua D.
- Beteiligte Personen und Organisationen
-
Yuzbasiyan-Gurkan, Vilma
Thamm, Douglas H.
Hamilton, Elizabeth
Kiupel, Matti
SpringerLink (Online service)
- DOI
-
10.1186/1746-6148-4-32
- URN
-
urn:nbn:de:1111-2016080545520
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Webster, Joshua D.
- Yuzbasiyan-Gurkan, Vilma
- Thamm, Douglas H.
- Hamilton, Elizabeth
- Kiupel, Matti
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
Interleukin-2 receptor expression in canine cutaneous mast cell tumors
Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
Gene expression profiling based identifications of potential prognostic molecular markers in decitabine treated acute myeloid leukemia
Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
Interleukin-2 receptor expression in canine cutaneous mast cell tumors
Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
Gene expression profiling based identifications of potential prognostic molecular markers in decitabine treated acute myeloid leukemia
Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
Interleukin-2 receptor expression in canine cutaneous mast cell tumors
Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
Gene expression profiling based identifications of potential prognostic molecular markers in decitabine treated acute myeloid leukemia